Congratulations to AGA President Maria T. Abreu, MD, AGAF, who was appointed to be the executive director of the F. Widjaja Inflammatory Bowel Disease Institute at Cedars-Sinai. In her new role, Dr. Abreu will direct IBD teaching and clinical activities, as well as basic, translational and clinical research. She will also collaborate with stakeholders to advance leading-edge care for patients.
Dr. Abreu will succeed director Stephan Targan, MD, her mentor and a former research colleague from more than two decades ago. She previously served as director of Basic and Translational Research in the Inflammatory Bowel Disease Center at Cedars-Sinai.
“My fundamental training as a physician-scientist occurred at Cedars-Sinai, and I believe it’s my destiny to return,” Dr. Abreu said. “With many of the current faculty having trained with me—whether at Cedars-Sinai or at the University of Miami—it is very exciting to be back among this expert team, and especially with Dr. Targan, who first inspired me to study IBD.”
